Sales of Tysabri, the multiple sclerosis drug it sells with Elan
Biogen's two other major drugs are solid workhorses. Cancer drug Rituxan and multiple sclerosis drug Avonex, which competes with Tysabri and other multiple sclerosis drugs like Teva Pharmaceuticals'
Unfortunately, the pipeline is in shambles. It's working on an oral multiple sclerosis drug, BG-12, but it's behind both Novartis
The company's new CEO, George Scangos, who came over from development-stage drugmaker Exelixis